Immunome
IMNM
IMNM
151 hedge funds and large institutions have $1.07B invested in Immunome in 2025 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
13.7% more ownership
Funds ownership: 91.29% → 104.98% (+14%)
6% more funds holding
Funds holding: 142 → 151 (+9)
90% less call options, than puts
Call options by funds: $4.89M | Put options by funds: $50.7M
Holders
151
Holding in Top 10
4
Calls
$4.89M
Puts
$50.7M
Top Buyers
| 1 | +$80.7M | |
| 2 | +$16.7M | |
| 3 | +$12.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.85M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$8.92M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$7.09M | |
| 3 | -$6.36M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$4.5M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.04M |
